Client of a consultant lobbyist
Stem Cell Network
- Meetings this Parliament
- 4
- With MPs
- 0
- Since Nov 2021
- 4
- Active registrations
- 1
Most recent reported meeting: Jul 22, 2026.
Lobbying by Stem Cell Network: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Consultant In effect since Jul 17, 2026 Receives government funding
Consultant Brian Klunder of Temple Scott Associates Inc.
Consultant lobbyists
-
Brian Klunder
Former public office holder
Formerly Policy Advisor, Minister's Office, Health Canada (2004–2006)
Formerly Policy Advisor, Minister's Office, Finance Canada (2003–2003)
Formerly Policy Advisor, Deputy Prime Minister's Office, PCO (2003–2003)
Formerly Special Assistant, Minister's Office, Transport Canada (2000–2002)
Institutions they may lobby: Finance Canada (FIN), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), National Defence (DND), Prime Minister's Office (PMO), Privy Council Office (PCO), Senate of Canada
What they're lobbying on (1)Hide details
- Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
Registration 761494-387204-1. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Brian Klunder · Consultant
- Alexa Kalsatos · Senior Operations and Regional Advisor (Ontario), National Defence (DND)
Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
-
Reported by Brian Klunder · Consultant
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
-
Reported by Brian Klunder · Consultant
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
-
Reported by Brian Klunder · Consultant
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.